Noty do jednostkowego sprawozdania finansowego na dzień 31 marca 2023 r.
Jednostkowe sprawozdanie finansowe wg MSSF na dzień 31 marca 2023 r.
AGM 02-06-2023
Walne zgromadzenie posiadaczy warrantów
Sales revenues for March 2023
Sofia, Bulgaria, April 20, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for March 2023 the Company recorded an increase in sales of 127% compared to the same month of the previous year, incl. 3% increase in domestic sales and 426% increase in export sales due to the low base in the previous period due to the collapse of sales in the main markets as a result of the conflict between Russia and Ukraine.
Prezentacja rocznego zbadanego jednostkowego sprawozdania finansowego „Sopharma” AD na dzień 31 grudnia 2022 r
Sprawozdania finansowe Formularze FSC
Roczne sprawozdanie finansowe za rok 2022 - format ESEF
Przychody ze sprzedaży za luty 2023 r
Sofia, Bulgaria, March 20, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for February 2023 the Company recorded an increase in sales of 20% compared to the same month of the previous year, incl. 41% increase in domestic sales and 10% increase in export sales.
For the first two months of 2023, sales increased by a total of 21%, incl. same level of domestic sales and 42% increase in export sales.
Strony
- « pierwsza
- ‹ poprzednia
- …
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- …
- następna ›
- ostatnia »